Stek advises shareholders of CAM Bioceramics in sale of majority stake to SHS Capital and ING Corporate Investments

The shareholders of CAM Bioceramics have sold a majority stake to SHS Capital, a German investor specialising in healthcare, and ING Corporate Investments and will remain involved as minority shareholders.

Bioceramics, based in Leiden, the Netherlands, is a leading global producer of innovative calcium phosphate solutions for Medtech and LifeScience applications.

Click here for the press release.

Lawyers

Practice Areas

This might also interest you

Stek advises on Open Heat Grid Delft

The municipality of Delft is advancing towards providing affordable and sustainable heating to its residents with the establishment of a …

Read more

Stek advises Stedin on equity issue to 23 provinces and municipalities as new shareholders

Stek has advised grid operator Stedin Group on an equity issue of € 34,8 million to 23 new shareholders being …

Read more

Stek again victorious for USG on allocation of costs for the transportation of electricity to SABIC

Stek has successfully represented Utility Support Group (USG) B.V. (“USG”) in the continuation of its dispute with SABIC Petrochemicals B.V. …

Read more